Characteristics of occult hepatitis B virus infection in the Solomon Islands

International Journal of Molecular Medicine

Volumn 27, Issue 6, 2011, Pages 829-834

  Utsumi, Takako ^a,b   Yano, Yoshihiko ^b   Truong, Bui Xuan ^c   Kawabata, Masato ^b   Hayashi, Yoshitake ^b  

^a AIRLANGGA UNIVERSITY   (Indonesia)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c BACH MAI HOSPITAL   (Viet Nam)

Author keywords

Community; Occult hepatitis B virus; Solomon Islands

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; ENDEMIC DISEASE; ETHNICITY; FEDERATED STATES OF MICRONESIA; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SOLOMON ISLANDS; WILD TYPE;

ADULT; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; MELANESIA; PHYLOGENY; PREVALENCE; VIRAL LOAD;

EID: 79954538745     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.660     Document Type: Article

References (22)

1. Gitlin N: Hepatitis B: diagnosis, prevention, and treatment. Clin Chem 43: 1500-1506, 1997.
2. Lee WM: Hepatitis B virus infection. N Engl J Med 337: 1733-1745, 1997.
3. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E and Raimondo G: Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126: 102-110, 2004. (Pubitemid 38040728)
4. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S and Paterlini-Bréchot P: Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely 'occult'? Hepatology 34: 194-206, 2001.
5. Yotsuyanagi H, Shintani Y, Moriya K, Fujie H, Tsutsumi T, Kato T, Nishioka K, Takayama T, Makuuchi M, Iino S, Kimura S and Koike K: Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus. J Infect Dis 181: 1920-1928, 2000.
6. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME and Raimondo G: Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341: 22-26, 1999. (Pubitemid 29293716)
7. Minuk GY, Sun DF, Uhanova J, Zhang M, Caouette S, Nicolle LE, Gutkin A, Doucette K, Martin B and Giulivi A: Occult hepatitis B virus infection in a North American community-based population. J Hepatol 42: 480-485, 2005. (Pubitemid 40342925)
8. Utsumi T, Yano Y, Truong BX, Tanaka Y, Mizokami M, Seo Y, Kasuga M, Kawabata M and Hayashi Y: Molecular epidemiological study of hepatitis B virus infection in two different ethnic populations from the Solomon Islands. J Med Virol 79: 229-235, 2007. (Pubitemid 46213186)
9. Furusyo N, Hayashi J, Kakuda K, Sawayama Y, Ariyama I, Eddie R aad Kashiwagi S: Markedly high seroprevalence of hepatitis B virus infection in comparison to hepatitis C virus and human T lymphotropic virus type-1 infections in selected Solomon Islands populations. Am J Trop Med Hyg 79: 85-91, 1999. (Pubitemid 29344994)
10. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Suzuki S, Kimura Y, Ueda R, Butterworth LA and Cooksley WG: A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol 82: 883-892, 2001. (Pubitemid 32280047)
11. Yamamura T, Tanaka E, Matsumoto A, Rokuhara A, Orii K, Yoshizawa K, Miyakawa Y and Kiyosawa K: A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter. J Med Virol 70: 545-552, 2003. (Pubitemid 36734718)
12. Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, Kawaguchi R, Tanaka S, Yoshiba M and Kohara M: Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 37: 2899-2903, 1999. (Pubitemid 29391907)
13. Sekiguchi S, Sato S, Kato T and Ikeda H: Effectiveness of a highly sensitive chemiluminescent immunoassay in screening for hepatitis B surface antigen in Japanese blood donors. Transfusion 39: 660-662, 1999.
14. Norder H, Couroucé AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S and Magnius LO: Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289-309, 2004. (Pubitemid 39541275)
15. Tanaka Y, Orito E, Yuen MF, Mukai de M, Sugauchi F, Ito K, Ozasa A, Sakamoto T, Kurbanov F, Lai CL and Mizokami M: Two subtypes (subgenotypes) of hepatitis B virus genotype C: a novel subtyping assay based on restriction fragment length polymorphism. Hepatol Res 33: 216-224, 2005. (Pubitemid 41794210)
16. Saitou N and Nei M: The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425, 1987.
17. Kumar S, Tamura K and Nei M: MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5: 150-163, 2004.
18. Fang ZL, Zhuang H, Wang XY, Ge XM and Harrison TJ: Hepatitis B virus genotypes, phylogeny and occult infection in aregion with a high incidence of hepatocellular carcinoma in China. World J Gastroenterol 10: 3264-3268, 2004. (Pubitemid 39585462)
19. Weinberger KM, Bauer T, Böhm S and Jilg W: High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 81: 1165-1174, 2000. (Pubitemid 30232700)
20. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L and Decker R: Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345: 1406-1407, 1995.
21. Lee PI, Chang LY, Lee CY, Huang LM and Chang MH: Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 176: 427-430, 1997.
22. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA and Mphahlele MJ: The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine 19: 3919-3926, 2001. (Pubitemid 32566315)